Exudative macular degeneration is the wet form of age-related macular degeneration (AMD). It develops when abnormal new blood vessels grow beneath the retina near the macula and leak fluid or blood. This leakage can damage the macula, which is responsible for sharp central vision.
What does exudative macular degeneration mean?
Exudative macular degeneration is another name for wet age-related macular degeneration. It is also called neovascular macular degeneration. These terms describe the same general condition rather than three different eye diseases.
The word exudative refers to the leakage of fluid from blood vessels. The term neovascular describes the growth of new blood vessels. In this condition, abnormal blood vessels develop underneath or near the retina and may leak fluid and blood into surrounding retinal tissue.
According to Cleveland Clinic, exudative and neovascular macular degeneration are formal names for wet macular degeneration. The terminology highlights two important features of the disease: abnormal blood vessel growth and leakage.
Which part of the eye does exudative macular degeneration affect?
The condition affects the macula, a small but important area near the center of the retina. The retina is the light-sensitive tissue lining the back of the eye. It receives light and sends visual information to the brain.
The macula provides detailed central vision. It helps with activities such as:
- Reading books, labels, and other printed material.
- Recognizing faces and facial expressions.
- Seeing fine details when cooking, sewing, or doing other close-up tasks.
- Looking directly at objects and signs.
- Seeing clearly when performing tasks that require detailed vision.
When fluid or blood leaks into the retinal layers around the macula, these tissues can become swollen or damaged. Over time, abnormal blood vessels may also lead to scarring. These changes can interfere with the way the macula processes visual information.
The National Eye Institute identifies wet AMD as an advanced, late-stage form of age-related macular degeneration that can cause faster vision loss than the dry form.
How is exudative macular degeneration different from dry macular degeneration?
Age-related macular degeneration has two main forms: dry and wet. Both affect the macula, but the changes inside the eye are different.
Dry macular degeneration
Dry AMD is the more common form. It develops when the macula becomes thinner over time. Small deposits called drusen may build up beneath the retina. Drusen are yellowish deposits that eye specialists can identify during an examination.
Dry AMD usually progresses gradually. Some people have no noticeable vision changes during its early stages, while others develop problems with central vision as the condition advances.
Wet or exudative macular degeneration
Wet AMD develops when abnormal blood vessels grow beneath the retina and leak fluid or blood. The leakage can cause swelling, damage to retinal tissue, and scarring around the macula.
Although wet AMD is less common than dry AMD, it can affect vision more quickly. It is always classified as late-stage AMD. Some people with dry AMD may later develop the wet form, although this does not happen to everyone.
MedlinePlus, a health information service of the US National Library of Medicine, explains that dry AMD generally causes slower changes, while wet AMD involves abnormal blood vessels that leak fluid and blood and can damage the macula more quickly.
Why do abnormal blood vessels grow in the macula?
In wet AMD, abnormal blood vessel growth is an important part of the disease process. These vessels develop in the wrong location beneath the retina and are more likely to leak than normal retinal blood vessels.
A protein called vascular endothelial growth factor (VEGF) helps regulate blood vessel growth. In wet AMD, VEGF contributes to the development of abnormal vessels in the back of the eye. These vessels can leak fluid and blood, affecting the structure and function of the macula.
This process is also why medications called anti-VEGF drugs are commonly used to treat wet AMD. They help block the activity of VEGF and reduce leakage from abnormal blood vessels.
What changes in vision can exudative macular degeneration cause?
Exudative macular degeneration mainly affects central vision. The changes may develop relatively quickly or gradually, depending on the individual and the activity of the disease.
Possible visual changes include:
- Blurry central vision: Objects directly in front of the eyes may become less clear.
- Distorted straight lines: Door frames, window edges, or lines on a page may appear bent or wavy.
- Dark or blank areas: A dark patch or missing area may appear near the center of vision.
- Reduced color brightness: Colors may appear less vivid than before.
- Difficulty recognizing faces: Damage to central vision may make facial details harder to see.
- Problems with reading: Letters or words may become blurry, distorted, or difficult to follow.
These changes do not necessarily affect peripheral vision, which is the ability to see objects away from the direct line of sight. However, central vision loss can make everyday activities more difficult.
The MedlinePlus guide to macular degeneration describes blurry central vision, wavy lines, dark spots, and reduced color brightness among the possible changes associated with late-stage AMD. New distortion or a sudden change in vision should be assessed by an eye care specialist promptly.
How do eye specialists identify exudative macular degeneration?
An ophthalmologist, particularly a retina specialist, can assess the macula and look for signs of abnormal blood vessels or fluid leakage. The evaluation usually includes an eye examination and may involve specialized imaging tests.
Dilated eye examination
Eye drops are used to widen the pupils so the specialist can examine the retina. This helps the doctor look for changes in the macula, including deposits, bleeding, swelling, and other signs of AMD.
Optical coherence tomography (OCT)
OCT is a noninvasive imaging test that creates detailed pictures of the retinal layers. It helps the specialist examine the macula and identify structural changes, including fluid within or beneath the retina.
Fluorescein angiography
In some cases, a dye is injected into a vein in the arm. A camera then takes photographs as the dye moves through the blood vessels at the back of the eye. This can help identify abnormal blood vessels and areas of leakage.
The NHS guidance on diagnosing AMD describes eye examinations and retinal imaging as part of the assessment process. The tests selected depend on the findings and the information the specialist needs.
Why is the term exudative macular degeneration used in medical care?
The term helps healthcare professionals identify the type of macular degeneration affecting the eye. It is useful because wet and dry AMD involve different changes in retinal tissue and may require different management approaches.
When a medical report describes exudative AMD, it generally indicates that abnormal blood vessels and leakage are involved. The terms wet AMD and neovascular AMD may be used to describe the same condition.
Recognizing the wet form is particularly important because it has established treatment options. Unlike some forms of dry AMD, wet AMD can often be treated with medicines that target abnormal blood vessel growth.
What treatments are used for exudative macular degeneration?
Although treatment cannot always restore vision that has already been lost, it can help reduce further damage. The choice of treatment depends on the retinal findings, the extent of disease, and the response to previous care.
Anti-VEGF injections
Anti-VEGF injections are the most commonly used treatment for wet AMD. The medicine is injected into the eye by an appropriately trained eye specialist. It blocks VEGF activity, helping reduce abnormal blood vessel growth and leakage.
These injections often need to be repeated because their effects are temporary. The treatment schedule depends on how the eye responds and the specialist's assessment.
Photodynamic therapy
Photodynamic therapy (PDT) is another treatment option for selected cases. It uses a light-sensitive medicine called verteporfin, followed by a specific type of laser directed at abnormal blood vessels. The procedure aims to damage the unwanted vessels while limiting injury to surrounding tissue.
PDT is used less often than anti-VEGF injections and may sometimes be combined with them. The National Eye Institute's guidance on wet AMD treatment identifies anti-VEGF injections and photodynamic therapy as treatment options that can help slow or stop further vision loss.
When should someone seek an eye examination?
New or sudden changes in central vision should not be ignored. Straight lines that begin to look wavy, a new dark area in central vision, or unexplained distortion may be associated with changes in the macula.
Contact an eye care professional promptly when these changes occur, particularly if they are new or getting worse. Early assessment matters because wet AMD can progress more quickly than the dry form, and timely treatment may help preserve vision.
People already diagnosed with AMD should also follow the examination schedule recommended by their eye specialist. Monitoring is important because changes in one eye may not always be obvious when the other eye continues to see clearly.
Key points to remember
Exudative macular degeneration is the medical term for wet age-related macular degeneration. The name describes a condition in which abnormal blood vessels grow beneath the retina and leak fluid or blood near the macula.
It differs from dry AMD because abnormal blood vessel growth and leakage are central features of the wet form. The distinction is important for diagnosis and treatment planning. Eye examinations and retinal imaging help specialists identify these changes, while treatments such as anti-VEGF injections can help limit further vision loss.